- 23820287OWN - NLMSTAT- MEDLINEDA  - 20130703DCOM- 20131021IS  - 1538-943X (Electronic)IS  - 1058-2916 (Linking)VI  - 59IP  - 4DP  - 2013 Jul-AugTI  - Bivalirudin for treatment of aortic valve thrombosis after left ventricular      assist device implantation.PG  - 448-9LID - 10.1097/MAT.0b013e3182937a65 [doi]AB  - Ventricular assist devices are increasingly being used for mechanical support in       patients with advanced heart failure. However, thromboembolism remains a leading       cause of mortality in this population. We describe the successful treatment of      native aortic valve thrombosis with bivalirudin in a patient with factor V Leiden      mutation, who had undergone left ventricular assist device implantation,      preventing the need for further surgical intervention.FAU - Sarsam, Sinan HAU  - Sarsam SHAD  - Department of Heart Failure and Transplant, Texas Heart Institute at St. Luke's      Episcopal Hospital, Houston, Texas 77030, USA.FAU - Civitello, Andrew BAU  - Civitello ABFAU - Agunanne, Enoch EAU  - Agunanne EEFAU - Delgado, Reynolds MAU  - Delgado RMLA  - engPT  - Case ReportsPT  - Journal ArticlePL  - United StatesTA  - ASAIO JJT  - ASAIO journal (American Society for Artificial Internal Organs : 1992)JID - 9204109RN  - 0 (Antithrombins)RN  - 0 (Hirudins)RN  - 0 (Peptide Fragments)RN  - 0 (Recombinant Proteins)RN  - 128270-60-0 (bivalirudin)RN  - Aortic Valve DiseaseSB  - IMMH  - Antithrombins/*therapeutic useMH  - Aortic ValveMH  - Coronary Thrombosis/*drug therapy/etiologyMH  - FemaleMH  - Heart Defects, Congenital/*drug therapy/etiologyMH  - Heart Valve Diseases/*drug therapy/etiologyMH  - Heart-Assist Devices/*adverse effectsMH  - HirudinsMH  - HumansMH  - Middle AgedMH  - Peptide Fragments/*therapeutic useMH  - Recombinant Proteins/therapeutic useEDAT- 2013/07/04 06:00MHDA- 2013/10/22 06:00CRDT- 2013/07/04 06:00AID - 10.1097/MAT.0b013e3182937a65 [doi]AID - 00002480-201307000-00017 [pii]PST - ppublishSO  - ASAIO J. 2013 Jul-Aug;59(4):448-9. doi: 10.1097/MAT.0b013e3182937a65.